# A Study of a New Leishmania Vaccine Candidate ChAd63-KH

> **NCT02894008** · PHASE2 · COMPLETED · sponsor: **University of York** · enrollment: 24 (actual)

## Conditions studied

- Leishmaniasis, Cutaneous

## Interventions

- **DRUG:** ChAd63-KH

## Key facts

- **NCT ID:** NCT02894008
- **Lead sponsor:** University of York
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2019-09-30
- **Final completion:** 2019-12-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02894008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02894008, "A Study of a New Leishmania Vaccine Candidate ChAd63-KH". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT02894008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*